WASHINGTON, Nov. 3 -- The U.S. Department of Health and Human Services National Institutes of Health announced that it expects to award a cooperative agreement for psychedelics treatment research in substance use disorder. The agency description of the cooperative agreement states: "Psychedelic treatments are currently in clinical development for a range of mental disorders. Therapeutic areas undergoing active clinical research include alcohol and substance use disorders (ASUD). The exploration more ST